Correlation Between Fennec Pharmaceuticals and Eupraxia Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fennec Pharmaceuticals and Eupraxia Pharmaceuticals, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Eupraxia Pharmaceuticals.

Diversification Opportunities for Fennec Pharmaceuticals and Eupraxia Pharmaceuticals

0.0

Correlation Coefficient

Fennec Pharmaceuticals  Eupraxia Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Fennec and Eupraxia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Eupraxia Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Eupraxia Pharmaceuticals go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and Eupraxia Pharmaceuticals

If you would invest  616.00  in Fennec Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  30.00  from holding Fennec Pharmaceuticals or generate 4.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Fennec Pharmaceuticals  vs.  Eupraxia Pharmaceuticals

Fennec Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Fennec Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Eupraxia Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Eupraxia Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Fennec Pharmaceuticals and Eupraxia Pharmaceuticals

The main advantage of trading using opposite Fennec Pharmaceuticals and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.

The idea behind Fennec Pharmaceuticals and Eupraxia Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.